A phase IIb randomised-controlled trial of the FFAR1/FFAR4 agonist icosabutate in MASH. Harrison SA, Alkhouri N, Ortiz-Lasanta G, Rudraraju M, et al. J Hepatol 2025;83:293-303.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Harrison SA, Alkhouri N, Ortiz-Lasanta G, Rudraraju M, et al. A phase IIb randomised-controlled trial of the FFAR1/FFAR4 agonist icosabutate in MASH. J Hepatol 2025;83:293-303.
PMID: 39938653